dual glp-1/gip receptor agonists The Clinical Application of GLP-1RAs and Based on Pharmacological Mechanisms: A Review GLP-1 receptor agonists are increasingly
Description
Okun The New England Journal of Medicines recent publication of a randomized study of a GLP-1 agonist originally designed for diabetes, but applied to Parkinson's disease, has led to a flurry of excitement and to a mountain of questions
Obesity, defined as a body mass index (BMI) of greater than 30, 1 is an established risk factor for many of the most common types of cancer
Cardiovascular safety has been evaluated with both oral and subcutaneous semaglutide
Sure enough, the research team found that when mice were treated with a metabolite of B
Athletes might face additional side effects relating to sport performance
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
